[Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review].
- DOI
- 10.3760/cma.j.cn121090-20251126-00553
- Published
- 2026 Mar 14
- Container
- Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3760/cma.j.cn121090-20251126-00553,
title = {[Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review].},
author = {Wei QZ and Lu C and Jiang HW and Hu JB and Wu YH and Hu Y},
year = {2026},
journal = {Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi},
doi = {10.3760/cma.j.cn121090-20251126-00553},
url = {https://doi.org/10.3760/cma.j.cn121090-20251126-00553}
}RIS
TY - JOUR TI - [Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review]. AU - Wei QZ AU - Lu C AU - Jiang HW AU - Hu JB AU - Wu YH AU - Hu Y PY - 2026 JO - Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi DO - 10.3760/cma.j.cn121090-20251126-00553 UR - https://doi.org/10.3760/cma.j.cn121090-20251126-00553 ER -
APA
QZ, W., C, L., HW, J., JB, H., YH, W., & Y, H. (2026). [Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review].. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. https://doi.org/10.3760/cma.j.cn121090-20251126-00553
Source records
- pubmed · retrieved 2026-09-27T10:07:55.443Z